“This is a step towards optimizing the conditions for a successful clinical study on preterm born infants in the U.S.”, says CEO anna Sjöström
After recently obtaining the CB certificate for its medical device, Neola Medical is now intensively preparing for clinic. As part of these efforts, the company plans to conduct a clinical pilot study in collaboration with a neonatal unit in Sweden.
Read the entire article by BioStock here: BioStock article – Neola’s vd: Nu förbereder vi för klinisk studie i USA